JP2010506953A5 - - Google Patents

Download PDF

Info

Publication number
JP2010506953A5
JP2010506953A5 JP2009533511A JP2009533511A JP2010506953A5 JP 2010506953 A5 JP2010506953 A5 JP 2010506953A5 JP 2009533511 A JP2009533511 A JP 2009533511A JP 2009533511 A JP2009533511 A JP 2009533511A JP 2010506953 A5 JP2010506953 A5 JP 2010506953A5
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
compound
pharmaceutical composition
acceptable carrier
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009533511A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010506953A (ja
JP5343267B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/081685 external-priority patent/WO2008049027A1/en
Publication of JP2010506953A publication Critical patent/JP2010506953A/ja
Publication of JP2010506953A5 publication Critical patent/JP2010506953A5/ja
Application granted granted Critical
Publication of JP5343267B2 publication Critical patent/JP5343267B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009533511A 2006-10-17 2007-10-17 タラロゾール代謝物 Expired - Fee Related JP5343267B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85198906P 2006-10-17 2006-10-17
US60/851,989 2006-10-17
PCT/US2007/081685 WO2008049027A1 (en) 2006-10-17 2007-10-17 Talarazole metabolites

Publications (3)

Publication Number Publication Date
JP2010506953A JP2010506953A (ja) 2010-03-04
JP2010506953A5 true JP2010506953A5 (enExample) 2010-09-16
JP5343267B2 JP5343267B2 (ja) 2013-11-13

Family

ID=39314359

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009533511A Expired - Fee Related JP5343267B2 (ja) 2006-10-17 2007-10-17 タラロゾール代謝物

Country Status (10)

Country Link
US (2) US8188124B2 (enExample)
EP (1) EP2114895A4 (enExample)
JP (1) JP5343267B2 (enExample)
KR (1) KR101419965B1 (enExample)
CN (1) CN101611016B (enExample)
AU (1) AU2007311026B2 (enExample)
BR (1) BRPI0718310A2 (enExample)
CA (1) CA2667053C (enExample)
MX (1) MX2009004096A (enExample)
WO (1) WO2008049027A1 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9080145B2 (en) 2007-07-01 2015-07-14 Lifescan Corporation Single pluripotent stem cell culture
US9096832B2 (en) 2007-07-31 2015-08-04 Lifescan, Inc. Differentiation of human embryonic stem cells
ATE523585T1 (de) 2007-11-27 2011-09-15 Lifescan Inc Differenzierung menschlicher embryonaler stammzellen
CA2959401C (en) 2008-02-21 2021-12-07 Centocor Ortho Biotech Inc. Methods, surface modified plates and compositions for cell attachment, cultivation and detachment
KR101651661B1 (ko) 2008-06-30 2016-08-26 얀센 바이오테크 인코포레이티드 만능 줄기 세포의 분화
MX2011004563A (es) 2008-10-31 2011-06-01 Centocor Ortho Biotech Inc Diferenciacion de celulas madre embrionarias humanas al linaje endocrino pancreatico.
CN102272291B (zh) 2008-10-31 2018-01-16 詹森生物科技公司 人胚胎干细胞向胰腺内分泌谱系的分化
PL2366021T3 (pl) 2008-11-20 2017-12-29 Janssen Biotech, Inc. Hodowla pluripotencjalnych komórek macierzystych na mikronośnikach
PL2366022T3 (pl) 2008-11-20 2016-11-30 Sposoby i kompozycje do przyłączania i hodowli komórek na podłożach planarnych
KR20170118969A (ko) 2009-07-20 2017-10-25 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 분화
AU2010333839C1 (en) 2009-12-23 2016-07-21 Janssen Biotech Inc. Differentiation of human embryonic stem cells
CN107189979B (zh) 2010-03-01 2021-05-04 詹森生物科技公司 纯化衍生自多能干细胞的细胞的方法
KR101986176B1 (ko) 2010-05-12 2019-06-05 얀센 바이오테크 인코포레이티드 인간 배아 줄기 세포의 분화
AU2011296381B2 (en) 2010-08-31 2016-03-31 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
WO2012030539A2 (en) 2010-08-31 2012-03-08 Janssen Biotech, Inc. Differentiation of human embryonic stem cells
WO2012030540A2 (en) * 2010-08-31 2012-03-08 Janssen Biotech, Inc. Differentiation of pluripotent stem cells
US9248120B2 (en) 2011-08-23 2016-02-02 The Board Of Trustees Of The Leland Stanford Junior University Reversing intestinal inflammation by inhibiting retinoic acid metabolism
US9388386B2 (en) 2011-12-22 2016-07-12 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into single hormonal insulin positive cells
CA2866590A1 (en) 2012-03-07 2013-09-12 Janssen Biotech, Inc. Defined media for expansion and maintenance of pluripotent stem cells
WO2013184888A1 (en) 2012-06-08 2013-12-12 Janssen Biotech, Inc. Differentiation of human embryonic stem cells into pancreatic endocrine cells
WO2014105543A1 (en) 2012-12-31 2014-07-03 Janssen Biotech, Inc. Culturing of human embryonic stem cells at the air-liquid interface for differentiation into pancreatic endocrine cells
RU2687379C2 (ru) 2012-12-31 2019-05-13 Янссен Байотек, Инк. Суспендирование и кластеризация плюрипотентных клеток человека с целью их дифференцировки в панкреатические эндокринные клетки
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
RU2684215C2 (ru) 2012-12-31 2019-04-04 Янссен Байотек, Инк. Способ получения панкреатических эндокринных клеток (варианты) и способ увеличения выхода бета-клеток
JP6588969B2 (ja) 2014-05-16 2019-10-09 ヤンセン バイオテツク,インコーポレーテツド 膵内分泌細胞内のmafa発現を強化するための小分子の使用
JP6705911B2 (ja) 2016-04-14 2020-06-03 ヤンセン バイオテツク,インコーポレーテツド 多能性幹細胞の中腸内胚葉細胞への分化

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0907650B1 (en) * 1996-06-27 2002-12-04 Janssen Pharmaceutica N.V. N- 4-(heteroarylmethyl)phenyl]-heteroarylamines
AP869A (en) 1998-01-05 2000-09-04 Pfizer 2,3-Substituted indole compounds as anti-inflammatory and analgesic agents.
IL162533A0 (en) * 2001-12-19 2005-11-20 Atherogenics Inc Chalcone derivatives and their use to treat diseases
US20060205945A1 (en) * 2004-05-14 2006-09-14 Pfizer Inc Pyrimidine derivatives for the treatment of abnormal cell growth
PL372356A1 (pl) * 2005-01-20 2006-07-24 ADAMED Sp.z o.o. Nowe związki, pochodne kwasu 3-fenylopropionowego
TW200639163A (en) * 2005-02-04 2006-11-16 Genentech Inc RAF inhibitor compounds and methods

Similar Documents

Publication Publication Date Title
EP2396081B1 (en) Alkylamido compounds and uses thereof
JP5343267B2 (ja) タラロゾール代謝物
RU2007119380A (ru) Косметические продукты, предназначенные для ухода за собой, включающие соли дигидроксипропилтри (c1-c3алкил) аммония
JP2010519270A5 (enExample)
JP2010530373A5 (enExample)
JP2013515006A5 (enExample)
JP2007511546A5 (enExample)
JP2012144574A5 (enExample)
JP2009543799A5 (enExample)
JP2007302689A5 (enExample)
JP2007515465A5 (enExample)
MA30352B1 (fr) Pyridine [3,4-b] pyrazinones
JP2013533861A5 (enExample)
JP2015536947A5 (enExample)
JP2013523623A5 (enExample)
JP2006515613A5 (enExample)
JP2015522547A5 (enExample)
EP2308828A3 (en) CaSR antagonist
MX337396B (es) Metodo para el tratamiento de enfermedades del riñon poliquisticas con derivados de ceramica.
JP2018145180A5 (enExample)
EA022994B1 (ru) Способ подавления толерантности к опиоидному анальгетику
JP2007532632A5 (enExample)
JP2004502684A5 (enExample)
JP2012524070A5 (enExample)
JP2008074845A5 (enExample)